Navigation Links
HeartWare Receives Third Patient Allotment From FDA - Authorizing 94 Additional Patients - Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
Date:1/24/2011

FRAMINGHAM, Mass. and SYDNEY, Jan. 24, 2011 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a third allotment, of 94 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).  The FDA granted two prior allotments of 54 patients each in April and September 2010, and the final patient from the second cohort was implanted earlier this month.

HeartWare's ADVANCE clinical trial is an FDA approved IDE study designed to evaluate the HeartWare® Ventricular Assist System as a bridge to heart transplantation for patients with end-stage heart failure.  Under the ADVANCE study, 140 patients at 30 U.S. clinical sites received HeartWare HVAD® pumps, making it the largest bridge-to-transplant pivotal trial to date.  HeartWare submitted to the FDA a Pre-Market Approval (PMA) application seeking approval of the HeartWare System for the bridge-to-transplant indication in December 2010.

Patient enrollment under the third CAP can now commence at the 30 centers participating in the ADVANCE clinical trial, subject to Institutional Review Board approvals at these sites.  

About HeartWare InternationalHeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implante
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference
2. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
3. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
4. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
5. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
6. HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference
7. HeartWare Achieves Primary Endpoint with 92% Success in Pivotal Bridge-to-Transplant Clinical Trial, ADVANCE
8. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
9. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
10. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
11. HeartWare to Report Financial Results for Third Quarter of 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014  Georgia-Pacific Professional ... towels and tissue for a wide range of ... of its product lines in healthcare, including hospitals, ... Georgia-Pacific Professional is introducing its healthcare products and ... Professional understands the importance of infection control in ...
(Date:9/30/2014)... 2014 In a recent study ... backflow of the Eldor spinal needle 25G, 103 mm ... pencil point spinal needles of the same gauge and ... anesthesia is an excellent type of regional anesthesia for ... etc. It is estimated that 100 million ...
(Date:9/30/2014)... ST. PAUL, Minn. , Sept. 30, 2014 /PRNewswire/ ... the United States abused prescription pain ... dependence include detoxification or maintenance treatment, which entails the ... and costs of these treatments are important when developing ... studies by pharmacy benefit manager Prime Therapeutics ...
Breaking Medicine Technology:Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3
... (Nasdaq: ARAY ), the premier radiation oncology ... present at the Oppenheimer Healthcare Conference in New York ... EST/10:00 a.m. PST.  A live webcast ... Investor Relations page of the Company,s website at ...
... Foundation for Infectious Diseases (NFID) joins the Centers for ... of influenza prevention during National Influenza Vaccination Week, December ... holiday season and beyond. Influenza vaccination rates ... years, but many parents remain unaware that annual vaccination ...
Cached Medicine Technology:National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4
(Date:9/30/2014)... 30, 2014 Speaking on this occasion, ... observed ‘Nursing Conference’ as a remarkable event, which brings ... medical and clinical research and diagnostic companies, leading universities ... a perfect platform to share experience, foster collaborations across ... world. Nursing Conference is a forum to explore issues ...
(Date:9/30/2014)... New Zealand (PRWEB) September 30, 2014 ... the potential to improve breast cancer risk prediction ... according to a study published in Breast Cancer ... “Digital mammographic density and breast cancer risk: a ... demonstrates a strong connection between breast density and ...
(Date:9/30/2014)... and its partners successfully established a visual mapping ... myeloid derived suppressor cells (MDSC). The damage and ... understood, however this is a major stepping stone ... by tumor-derived factors from precursors present in hematopoietic ... spleen. This population of cells suppresses the activity ...
(Date:9/30/2014)... A recent study completed at the University of Eastern ... the risk of coronary heart disease. The sources of ... The findings were published in Arteriosclerosis, Thrombosis & ... Heart Association. , Recent studies have not found an ... risk of cardiovascular diseases. It seems that the mere ...
(Date:9/30/2014)... 2014 This two-day, advanced PT ... sequellae that may arise following a concussion or ... can be varied, from sports related injuries, car accidents, ... by the thousands of returning soldiers from war zone ... and blunt traumas can result in similar injuries, the ...
Breaking Medicine News(10 mins):Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4Health News:Dietary polyunsaturated fatty acids linked to smaller risk of coronary heart disease 2Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 2Health News:North American Seminars Presents Traumatic Brain Injury and Concussions in Conduction with St. Anthony's Medical Center in St. Louis, MO on November 8-9, 2014 3
... WHO has revealed that Africa's TB crisis has its origin ... of the two million people who die from TB every ... nurse at the African Medical and Research Foundation (AMREF) clinic ... who succumbed to TB were also infected with HIV. According ...
... study conducted by Columbia University Medical Center has ... in osteoarthritis, could be effective// in the treatment ... drug treatment with Cox-2 inhibitors or surgery was ... chronic shoulder pain. ,Approximately 1.5 million ...
... to World Health Organization (WHO), two fresh cases of ... from Mudug region//, in southern Somalia and northeastern Somalia ... to neighbouring countries. ,The cases also threaten ... the outbreak which has affected a total of 199 ...
... shoulder pain were left with only two options previously, either ... the safety concerns surrounding Vioxx and other Cox-2 inhibitors were ... has found that sodium hyaluronate, a drug approved by FDA ... for treating the shoulder pain. ,The study was ...
... Transesophageal echocardiography (TEE) is a recent progress in echocardiography ... procedure entails the insertion of a // probe into ... off the heart and help in enabling a motion ... echocardiogram. , ,These detailed images are capable of ...
... and Drug Administration (FDA) approved asthma Flovent HFA for kids ... a reformulation of Flovent that uses the more environmentally friendly ... the canister. ,It is an inhaled corticosteroid that ... , The medication initially was approved by the FDA ...
Cached Medicine News:Health News:Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 3
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: